• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人肺炎球菌疫苗接种的简易方法

A Simple Approach to Pneumococcal Vaccination in Adults.

作者信息

Green Calvin, Moore Christine Ann, Mahajan Akhilesh, Bajaj Kailash

机构信息

Department of Internal Medicine, East Tennessee State University James H. Quillen College of Medicine, Johnson City, TN, USA.

出版信息

J Glob Infect Dis. 2018 Jul-Sep;10(3):159-162. doi: 10.4103/jgid.jgid_88_17.

DOI:10.4103/jgid.jgid_88_17
PMID:30166816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6100338/
Abstract

is a bacterium responsible for a spectrum of diseases including lobar pneumonia, meningitis, otitis media, and sinusitis. Invasive pneumococcal disease is responsible for significant morbidity and mortality across the world. Concerted efforts led to the development of two vaccinations, Pneumova × 23 and Prevnar 13, for the prevention of pneumococcal disease. The Advisory Committee on Immunization Practices of the US Centers for Disease Control and Prevention provides vaccination schedules for predisposed adults, but the proposed schedules remain a challenge to health-care providers. We performed a systematic review in PubMed and these specialty group websites to present the pathophysiology of pneumococcal disease, outline different pneumococcal vaccinations, and condense recommendations for vaccination administration.

摘要

是一种可导致多种疾病的细菌,包括大叶性肺炎、脑膜炎、中耳炎和鼻窦炎。侵袭性肺炎球菌疾病在全球范围内导致了显著的发病率和死亡率。共同努力促成了两种预防肺炎球菌疾病的疫苗的研发,即23价肺炎球菌多糖疫苗(Pneumova × 23)和13价肺炎球菌结合疫苗(Prevnar 13)。美国疾病控制与预防中心免疫实践咨询委员会为易感成年人提供了疫苗接种时间表,但拟议的时间表对医疗保健提供者来说仍是一项挑战。我们在PubMed和这些专业组织网站上进行了系统综述,以阐述肺炎球菌疾病的病理生理学,概述不同的肺炎球菌疫苗,并归纳疫苗接种管理的建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ea/6100338/3a5a06ec10de/JGID-10-159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ea/6100338/0f548b7c8d81/JGID-10-159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ea/6100338/3a5a06ec10de/JGID-10-159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ea/6100338/0f548b7c8d81/JGID-10-159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ea/6100338/3a5a06ec10de/JGID-10-159-g002.jpg

相似文献

1
A Simple Approach to Pneumococcal Vaccination in Adults.成人肺炎球菌疫苗接种的简易方法
J Glob Infect Dis. 2018 Jul-Sep;10(3):159-162. doi: 10.4103/jgid.jgid_88_17.
2
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌病-使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗-免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.
3
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.《免疫实践咨询委员会关于 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗在年龄≥65 岁成人中使用的更新建议》。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5.
4
Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).更新的 23 价肺炎球菌多糖疫苗(PPSV23)预防成人侵袭性肺炎球菌病的建议。
MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.
5
Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.2010 年,免疫实践咨询委员会(ACIP)批准了 13 价肺炎球菌结合疫苗(PCV13)并提出了其在儿童中的使用建议。
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61.
6
Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines.成人肺炎球菌疾病的预防:肺炎球菌疫苗的使用策略
Vaccine. 2015 Nov 27;33 Suppl 4:D60-5. doi: 10.1016/j.vaccine.2015.05.102. Epub 2015 Jul 9.
7
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.13价肺炎球菌结合疫苗在70岁及以上曾接种23价肺炎球菌多糖疫苗的成年人中的免疫原性和安全性。
Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18.
8
Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017.2011 年至 2017 年日本成人肺炎链球菌性肺炎患者中肺炎链球菌血清型的分布及年度变化。
J Infect Chemother. 2019 Nov;25(11):925-929. doi: 10.1016/j.jiac.2019.07.007. Epub 2019 Jul 24.
9
Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.肺炎球菌疫苗推荐的最新进展与未来方向
Clin Ther. 2015 May 1;37(5):928-34. doi: 10.1016/j.clinthera.2015.03.025. Epub 2015 Apr 23.
10
Vaccination recommendations and risk of meningitis following cochlear implantation.人工耳蜗植入后的疫苗接种建议及脑膜炎风险
Curr Opin Otolaryngol Head Neck Surg. 2014 Oct;22(5):359-66. doi: 10.1097/MOO.0000000000000092.

引用本文的文献

1
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group.肺炎研究中的未满足需求:CAPNETZ 研究小组的综合方法。
Respir Res. 2022 Sep 10;23(1):239. doi: 10.1186/s12931-022-02117-3.
2
What should define a SARS-CoV-2 "breakthrough" infection?什么应该定义为新冠病毒的“突破性”感染?
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI151186.

本文引用的文献

1
Navigating pneumococcal vaccination in adults.成人肺炎球菌疫苗接种导航。
Cleve Clin J Med. 2016 Jun;83(6):427-33. doi: 10.3949/ccjm.83a.15044.
2
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.13 价肺炎球菌结合疫苗对美国儿童肺炎球菌性脑膜炎的影响。
Clin Infect Dis. 2015 Sep 1;61(5):767-75. doi: 10.1093/cid/civ368. Epub 2015 May 13.
3
Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.15价肺炎球菌结合疫苗在健康成年人中的安全性、耐受性和免疫原性。
Vaccine. 2015 Jun 4;33(24):2793-9. doi: 10.1016/j.vaccine.2015.04.025. Epub 2015 Apr 23.
4
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.多糖结合疫苗预防成人肺炎球菌性肺炎。
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
5
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).《65 岁及以上成人中使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗:免疫实践咨询委员会(ACIP)的建议》。
MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.
6
Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.美国引入13价结合疫苗后肺炎球菌血清型及抗菌药物耐药性的变化
Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.
7
Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes.基于人群的侵袭性无荚膜肺炎球菌分析显示,大多数菌株的荚膜合成基因存在缺陷。
PLoS One. 2014 May 15;9(5):e97825. doi: 10.1371/journal.pone.0097825. eCollection 2014.
8
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.60-64 岁未曾接种过肺炎球菌疫苗的成年人中序贯接种 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗。
Vaccine. 2014 Apr 25;32(20):2364-74. doi: 10.1016/j.vaccine.2014.02.002. Epub 2014 Mar 5.
9
Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward.肺炎球菌肺炎的诊断:当前的陷阱与未来方向
Infect Chemother. 2013 Dec;45(4):351-66. doi: 10.3947/ic.2013.45.4.351. Epub 2013 Dec 27.
10
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.在未接种过肺炎球菌疫苗的成年人中,13价肺炎球菌结合疫苗与23价肺炎球菌多糖疫苗的免疫原性和安全性比较
Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18.